Stockreport

Codexis Inc (CDXS) Reports Fiscal Year 2023 Financial Results [Yahoo! Finance]

Codexis, Inc.  (CDXS) 
Last codexis, inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.codexis.com/investors
PDF Product Revenues : $42.9 million for FY 2023, including PAXLOVID enzyme sales, down from $116.7 million in FY 2022. R&D Revenues : Increased to $27.2 million in FY 20 [Read more]